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Semi-quantitative assessment of right
ventricular function in comparison to a 3D
volumetric approach: A cardiovascular
magnetic resonance study
Abstract Right ventricular (RV) vol-
ume measurements with cardiovascu-
lar magnetic resonance (CMR) is
considered the gold standard, but
acquisition and analysis remain time-
consuming. The aim of our study was
therefore to investigate the accuracy
and performance of a semi-quantita-
tive assessment of RV function in
CMR, compared to the standard
quantitative approach. Seventy-five
subjects with pulmonary hypertension
(15), anterior myocardial infarction
(15), inferior myocardial infarc-
tion (15), Brugada syndrome (15)
and normal subjects (15) underwent
cine CMR. RV end-systolic and end-
diastolic volumes were determined to
calculate RV ejection fraction (EF).
Four-chamber cine images were used
to measure tricuspid annular plane
systolic excursion (TAPSE). RV frac-
tional shortening (RVFS) was calcu-
lated by dividing TAPSE by the RV
end-diastolic length. RV EF correlated
significantly with TAPSE (r = 0.62,
p < 0.01) and RVFS (r = 0.67, p < 0.01).
Sensitivity to predict RV dysfunction
was comparable between TAPSE and
RVFS, with higher specificity for
RVFS, but comparable areas under the
ROC curve. Intra- and inter-observer
variability of RV EF was better than
TAPSE (3%/4% versus 7%/15%,
respectively). For routine screening in
clinical practice, TAPSE and RVFS
seem reliable and easy methods to
identify patients with RV dysfunction.
The 3D volumetric approach is pre-
ferred to assess RV function for
research purposes or to evaluate
treatment response.
Keywords Cardiovascular magnetic
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Introduction
Right ventricular (RV) function has proven to be of
significant importance in a wide range of cardiac disease. It
is a major determinant of clinical outcome in chronic heart
failure, a prognostic marker for adverse outcome after acute
myocardial infarction and an important measure in the
evaluation and follow-up of patients with pulmonary arterial
hypertension [1–4]. Thus, the need for diagnosis of RV
dysfunction is evident. Various (non)invasive imaging
modalities are available for the evaluation of RV function
[5–10], of which cardiovascular magnetic resonance (CMR)
is considered the gold standard for quantitative assessment
[11, 12]. Although assessment of RV volumes and function
using CMR is highly accurate and reproducible [13, 14], both
acquisition and analysis are still time-consuming and require
dedicated post-processing software. In clinical practice, 2D
echocardiography is generally used to acquire functional
information of the RV. A quick semi-quantitative approach to
assess RV function in 2D echocardiography is to measure the
tricuspid annular plane systolic excursion (TAPSE), which
can easily be obtained, and correlates well with RV function
on radionuclide angiography [15–17].
The increasing interest and availability of clinical CMR
generates the need for fast and accurate methods to obtain
information on RV function and dimensions. For left
ventricular analysis, geometrical models have been devel-
oped to accurately determine left ventricular function and
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dimensions and to substantially reduce acquisition and
analysis duration [18]. However, this approach often fails
in RV analysis, while its geometrical complexity impedes
the accuracy of such models to determine function and
volumes. Some clinicians therefore measure a modified
TAPSE, adapted from echocardiography. However, it is
unknown whether this semi-quantitative approach can be
legitimately used in CMR and how it relates to the
quantitative assessment of RV function. Furthermore, it is
disputable whether an absolute TAPSE value accurately
represents RV function in all patients, while this measure
disregards the dimensions of the RV. Therefore, it may be
more accurate to use a semi-quantitative measure that
involves RV dimensions to determine RV function.
The present study was designed to determine the
accuracy of a semi-quantitative assessment of RV function
in CMR and to evaluate its diagnostic performance for
identifying different degrees of RV dysfunction. Further-
more, we sought to investigate the intra-observer and inter-
observer reproducibility of this method, compared to the
standard quantitative approach.
Materials and methods
Subject selection
Patients for the study were recruited from the clinic at the
cardiology department of the VU University Medical Center,
Amsterdam, the Netherlands. We prospectively investigated
60 patients (39 men; mean age, 50±13 years), consecutively
enrolled per each patient group. The study population
consisted of 15 patients with pulmonary arterial hyperten-
sion, 15 patients with anterior acute myocardial infarction
(AMI), 15 patients with inferior AMI and 15 patients with
Brugada syndrome. Pulmonary arterial hypertension (11
idiopathic, 4 systemic sclerosis) was confirmed by cardiac
catheterization (mean pulmonary artery pressure, 54 ±
16 mmHg). Patients with AMI were scanned 5 ± 2 days
after primary percutaneous coronary intervention with
stenting and were treated with aspirin, heparin, abciximab,
clopidogrel, statins, beta-blockade and ACE-inhibitors. The
Brugada syndrome was confirmed by typical ECG-pattern
and a positive ajmaline test [19]. We also included 15 healthy
controls without cardiac history or risk factors in the study (5
men; mean age, 41 ± 12 years). Exclusion criteria comprised
contraindications for CMR (e.g., claustrophobia, pace-
makers, very irregular heart rhythm and intracerebral
aneurysm clips). The study was approved by the local ethics
committee, and all patients gave written informed consent.
CMR study protocol
CMR examination was performed on a 1.5-T clinical MR
system (Magnetom Sonata, Siemens, Erlangen, Germany)
using a four-element phased-array cardiac receiver coil.
ECG-gated cine imaging was performed using a balanced
steady-state free precession pulse sequence, during re-
peated breath-holds of approximately 10 s. Long axis slices
were acquired in the three standard views (four-, three- and
two-chamber view), as well as a stack of short axis slices
with a typical slice thickness of 5 mm and a gap of 5 mm
between the slices, fully covering both ventricles from base
to apex. MR parameters were as follows: temporal
resolution between 35 to 50 ms, typical voxel size 1.5×
1.8 ×5.0 mm3, excitation angle 60°, receiver bandwidth
930 Hz/pixel, TR/TE 3.2/1.6 ms, matrix 256×156.
Data analysis and definitions
CMR data for the assessment of RV volumes were
analyzed on a personal computer using dedicated software
(Mass, Medis, Leiden, the Netherlands). On all short axis
cine slices, the endocardial borders of the RV were outlined
manually on end-diastolic (first cine phase of the R-wave
triggered acquisition) and end-systolic (image phase with
smallest cavity area) images, excluding trabeculae and
papillary muscles. RV end-diastolic volumes (EDV, ml)
and RVend-systolic volumes (ESV, ml) were calculated by
summation of discs, from which RV ejection fraction (EF,
%) could be derived. TAPSE measurements were calcu-
lated on a separate workstation (Centricity Radiology v6.1,
GE Medical Systems, Zeist, the Netherlands). On the four-
chamber view, the distance between the cutting edge of the
tricuspid annulus with the RV free wall and the RV apex
was measured in end-diastole (end-diastolic length, EDL,
mm) and end-systole (ESL, mm) (Fig. 1). TAPSE was
defined as the difference between RV EDL and ESL. An
additional relative measure was obtained, which corrects
TAPSE for the length of the RV. This right ventricular
fractional shortening (RVFS) was calculated as follows:
RVFS %ð Þ ¼ EDL ESLð Þ
EDL
 100
To test intra-observer and inter-observer variability of
RV EF and TAPSE measurements, analyses were repeated
by the same investigator, and a second investigator
respectively on the same images in 25 subjects, from 5
consecutive subjects in each group (RN, TG). Analysis of
the scans was performed in random order, with the
investigators blinded to medical history of the subject
and previous results.
Statistical analysis
Continuous variables with normal distribution are ex-
pressed as mean ± SD. Analysis of variances (ANOVA)was
used to compare differences between patient groups, and
Tukey’s post-hoc test was used for pair-wise comparison of
means. Pearson’s correlation coefficients (r) were calcu-
lated for the relation between RV EF, TAPSE and RVFS.
Correlation coefficients were compared using a Fisher’s Z
transformation. The TAPSE and RVFS value with the
highest sensitivity and specificity for predicting RV
dysfunction were calculated for RV EF <35%, <40% and
<45%, using receiver-operating characteristic (ROC) anal-
ysis. Comparison between ROC curves following the
method described by Hanley and McNeil [20] was
performed using Analyse-it Clinical Laboratory 1.73
(Analyse-It Software, Ltd.).
Intra-observer and inter-observer variability of RV EF
and TAPSE measurements was assessed as previously
described by Bland and Altman [21], and the coefficients
of variability (SD of the differences of two measurements
divided by their mean) were calculated. A one-sample t test
against zero was performed to test for statistical signifi-
cance of the observed differences in intra-observer and
inter-observer variability.
All statistical tests were two-sided with a significance
level of p < 0.05. SPSS 12.0.1 for Windows (SPSS Inc.)
was used for all analyses, except for the comparison
between ROC curves.
Results
RV volumes, EF, lengths, TAPSE and RVFS are listed in
Table 1 according to patient groups. Healthy volunteers
and patients with Brugada syndrome were significantly
younger than patients with anterior/inferior AMI (p <
0.05). Patients with anterior AMI had larger infarcts than
patients with inferior AMI (21 ± 12 versus 13 ± 9 percent of
Fig. 1 Schematic figure of TAPSE measurement using a four-
chamber cine image in end-diastole (A) and end-systole (B). TAPSE
is calculated by subtracting the right ventricular end-systolic length
(grey line in panel B) from the end-diastolic length (gray line in
panel A). Clinical example of a four-chamber cine image in end-
diastole (C) and end-systole (D) in a patient with pulmonary
hypertension. The TAPSE measures 125.90–113.85=12.05 mm,
and the RVFS is 125:90113:85ð Þ125:90  100 ¼ 9:57%. RA: right atrium,
RV: right ventricle, LA: left atrium, LV: left ventricle
the left ventricle, p < 0.05). RV EDVi (indexed for body
surface area) and RV ESVi were higher and RV EF was
lower in patients with pulmonary arterial hypertension
compared to patients with anterior/inferior AMI and
Brugada syndrome (p < 0.05). RV ESVi, RV EDL and
RV ESL were significantly higher and RV EF, TAPSE
and RVFS lower in patients with pulmonary hypertension
than in healthy volunteers (p < 0.05). There were no
differences in RV indices between patients with anterior or
inferior AMI (p = ns).
Table 1 Subject characteristics and CMR measurements of the right ventricle per patient group and as a whole
Controls (n=15) PHT (n=15) Anterior AMI (n=15) Inferior AMI (n=15) Brugada (n=15) Total (n=75)
Age (years) 41 ± 12 47 ± 13 56 ± 10 55 ± 10 42 ± 12 48 ± 13
Peak CK (U/l) – – 3,755 ± 1,856 2,736 ± 1,939 – –
Infarct size (% LV) – – 22 ± 12 13 ± 9 – –
EDV (ml) 192 ± 37 248 ± 93 158 ± 34 175 ± 57 188 ± 47 192 ± 64
EDVi (ml/m2) 103 ± 15 130 ± 38 80 ± 14 87 ± 27 101 ± 17 100 ± 29
ESV (ml) 96 ± 20 188 ± 97 79 ± 24 89 ± 31 97 ± 28 110 ± 62
ESV i (ml/m2) 52 ± 10 98 ± 44 40 ± 10 44 ± 15 52 ± 12 57 ± 30
SV (ml) 96 ± 21 61 ± 30 79 ± 19 86 ± 30 92 ± 24 83 ± 27
SV i (ml/m2) 51 ± 8 32 ± 15 40 ± 10 42 ± 14 49 ± 10 43 ± 13
EF (%) 50 ± 5 27 ± 14 51 ± 8 49 ± 8 49 ± 7 45 ± 13
EDL (mm) 91 ± 8 103 ± 12 93 ± 10 98 ± 13 95 ± 9 96 ± 11
ESL (mm) 69 ± 7 89 ± 13 76 ± 12 78 ± 11 72 ± 9 77 ± 12
TAPSE (mm) 23 ± 3 15 ± 6 18 ± 5 20 ± 4 23 ± 4 20 ± 5
RVFS (%) 25 ± 3 14 ± 7 19 ± 6 21 ± 3 24 ± 4 21 ± 6
PHT: pulmonary arterial hypertension, AMI: acute myocardial infarction, CK: creatine kinase, LV: left ventricle, EDV: end-diastolic
volume, ESV: end-systolic volume, SV: stroke volume, -i: indexed for body surface area, EF: ejection fraction, EDL: end-diastolic length,
ESL: end-systolic length, TAPSE: tricuspid annular plane systolic excursion, RVFS: right ventricular fractional shortening
Values are expressed as mean ± SD
Fig. 2 Linear regression (solid line) of tricuspid annular plane systolic excursion (A) and right ventricular fractional shortening (B) by right
ventricular ejection fraction. Symbols represent groups according to legend
The RV EF as estimated by CMR showed significant
correlation to TAPSE (r=0.62, p<0.01, Fig. 2A). The
relationship between RV EF and RVFS was also
statistically significant (r=0.67, p<0.01, Fig. 2B). There
were no significant differences between both correlation
coefficients (Zobs=0.52). The TAPSE and RVFS cut-off
values with the highest sensitivity and specificity for
predicting RV EF <35%, <40% and 45% are listed in
Table 2. Figure 3 displays the ROC curves of TAPSE and
RVFS to indicate RV EF <35%. Specificity of RVFS was
higher than TAPSE to detect RV dysfunction; however,
comparison between the areas under the ROC curves of
TAPSE and RVFS revealed no statistical differences.
Figure 4 represents the Bland-Altman analyses of intra-
observer and inter-observer variabilities of RV EF and
TAPSE measurements. Intra-observer and inter-observer
variability of RV EF calculations was low (3% and 4%,
respectively). Although the intra-observer and inter-
observer variability of TAPSE measurements were
substantially higher (7% and 15%, respectively), the
differences in intra- and inter-observer variabilities of
both RV EF (p=0.74 and p=0.40, respectively) and TAPSE
(p=0.40 and p=0.56, respectively) were not statistically
significant.
Discussion
In the present study, we evaluated the accuracy and
performance of a semi-quantitative assessment of RV
function in CMR, and the intra-observer and inter-observer
reproducibility of this method, compared to the standard
quantitative approach. Our data demonstrate that TAPSE in
CMR correlates well with 3D volumetric assessment of RV
function. Intra-observer reproducibility was better than the
inter-observer reproducibility of TAPSE, but inferior to the
3D volumetric approach, which had comparable intra- and
inter-observer variability. Right ventricular fractional
shortening, which corrects for RV length, showed also
significant correlation with quantitative analysis.
Previous reports have demonstrated a relationship
between echocardiographic TAPSE and quantitative as-
sessment of RV function, using different modalities [22–
24]. In the present study, TAPSE acquired on CMR images
showed comparable normal ranges with previous studies in
echocardiography [25, 26], thus the described method for
CMR seems valid. The reason for a higher level of
correlation between TAPSE and RV EF in the present study
may be a larger study population with a wider range of RV
parameters than previously investigated. In addition, in
CMR it is possible to correct TAPSE for RV length, which
may offer a reliable semi-quantitative measure in small
hearts as well. RVFS tended to correlate better with RV
function than TAPSE and indicated impaired RV function
with comparable sensitivity but higher specificity than
TAPSE. Future research is needed to evaluate its possible
statistical superiority and clinical applicability.
In this study we used short axis orientation for
volumetric assessment of RV volumes [27–30]. Alfakih
and colleagues demonstrated that axial orientation results
in better observer variabilities than the short axis orien-
tation [31]. They suggest that the better identification of
the pulmonary and tricuspid valves, and the basal slice in
the axial orientation are mostly responsible for the
differences. In our study, we used the four-chamber view
to verify whether the basal short axis slice was part of the
RV and should be included in analysis, which resulted in
good reproducibility as well. Furthermore, in clinical
practice, short axis orientation allows both analysis of left
and right ventricular volumes and is therefore most often
used.
Table 2 The TAPSE and RVFS cut-off values with the highest sensitivity and specificity for predicting RV EF <35%, <40% and <45%
RV EF TAPSE RVFS
Cut-off value Sensitivity Specificity Cut-off value Sensitivity Specificity
<35% 18 100 73 17 100 86
<40% 17 75 81 17 75 86
<45% 18 70 79 19 67 85
Fig. 3 Receiver-operating characteristic curves of the TAPSE (solid
line) and RVFS (dashed line) to indicate right ventricular ejection
fraction of less than 35%. Area under the curves was 0.92 (0.85–
0.99) for TAPSE, versus 0.95 (0.90–1.00) for RVFS. There was no
statistical difference between both areas under the curve
The status of CMR as a highly reproducible reference
standard for the assessment of cardiac function is based on
its flexible multi-plane capabilities. The present study
offers directions to perform semi-quantitative measure-
ments for right ventricular function using CMR. Since RV
function provides important prognostic information, it is
desirable to have a screening tool to identify patients with
RV dysfunction. Both TAPSE and RVFS were validated for
this purpose and showed good performance, but also had
important limitations. For routine screening of the RV in a
standard clinical CMR examination, TAPSE and RVFS
seem reliable and easy methods to identify patients with
RV dysfunction. However neither TAPSE nor RVFS were
able to distinguish moderate and mildly depressed RV
function. For research purposes or when small changes in
RV function may have important clinical consequences,
e.g., for the evaluation of response to treatment, the more
time-consuming 3D volumetric approach is preferred to
assess RV function.
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Fig. 4 Bland-Altman plot illustrating the intra- and inter-observer variability of RV EF and TAPSE measurements. Mean difference (solid
line) and 95% limits of agreement (dashed lines) are shown
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